HMGB1 and Sepsis: Clinically, patients with sepsis have elevated serum levels of HMGB1, and these levels are associated with the severity of organ damage and death (14), suggesting that HMGB1-targeting strategies might be a viable option for clinical trials of sepsis and perhaps other inflammatory diseases.